Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Interest Expense : HK$-1,455 Mil (TTM As of Dec. 2023)

Shanghai Fosun Pharmaceutical (Group) Co Interest Expense Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Interest Expense		Get a 7-Day Free Trial					-1,195.86	-1,044.31	-1,007.17	-1,076.30	-1,449.07

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-296.02	-324.62	-348.23	-369.33	-412.53

Shanghai Fosun Pharmaceutical (Group) Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-1,455 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co  (HKSE:02196) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Fosun Pharmaceutical (Group) Co's Interest Expense for the three months ended in Dec. 2023 was HK$-413 Mil. Its Operating Income for the three months ended in Dec. 2023 was HK$96 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was HK$17,013 Mil.

Shanghai Fosun Pharmaceutical (Group) Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Shanghai Fosun Pharmaceutical (Group) Co Ltd interest coverage is 1.18, which is low.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Business Description